✦ LIBER ✦

Basal ganglia abnormalities in tardive dyskinesia

✍ Scribed by Paulo Dalgalarrondo; Wagner F. Gattaz

Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 648 KB
Volume: 244
Category: Article
ISSN: 1433-8491
DOI: 10.1007/bf02190380

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BAEP abnormalities in tardive dyskinesia

✍ J. Zeitlhofer; M. Brainin; Th. Reisner 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 221 KB

Abnormal sensory gating in basal ganglia

Abnormal sensory gating in basal ganglia disorders

✍ Ryuji Kaji; Ryou Urushihara; Nagako Murase; Hideki Shimazu; Satoshi Goto 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 283 KB

Bereitschaftspotential in tardive dyskin

Bereitschaftspotential in tardive dyskinesia

✍ Dr. Lawrence E. Adler; Mark Pecevich; Herbert Nagamoto 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

The bereitschaftspotential or motor readiness potential is a slow negative electroencephalographic wave occurring 150-1500 ms prior to the onset of a voluntary movement. It was measured in 33 subjects: 11 normal controls, 11 medicated schizophrenics with no tardive dyskinesia or evidence of drug-ind

Clozapine in tardive dyskinesia

✍ George M. Simpson; J. Hillary Lee; Ram K. Shrivastava 📂 Article 📅 1978 🏛 Springer 🌐 English ⚖ 468 KB

Naloxone in tardive dyskinesia

✍ I. Blum; P. F. Nisipeanu; E. Roberts 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 90 KB

Sulpiride in tardive dyskinesia

✍ Daniel E. Casey; Jes Gerlach; Hans Simmelsgaard 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 407 KB

Tardive dyskinesia can be suppressed by drugs that block dopaminergic receptors, but often at the cost of a concomitant increase in parkinsonism. Sulpiride (400 -- 2100 mg/day), a selective type-2 dopamine receptor antagonist, was evaluated in a blind, placebo-controlled trial in 11 patients with ta